American Bio Medica Corporation (ABMC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2022 | 6000.00 USD | 100.0% |
| 2021 | 3000.00 USD | -99.74% |
| 2020 | 1.16 Million USD | -1.69% |
| 2019 | 1.18 Million USD | 49.68% |
| 2018 | 789 Thousand USD | 2.2% |
| 2017 | 772 Thousand USD | 2.52% |
| 2016 | 753 Thousand USD | -20.32% |
| 2015 | 945 Thousand USD | 180.42% |
| 2014 | 337 Thousand USD | 171.77% |
| 2013 | 124 Thousand USD | 0.0% |
| 2012 | 124 Thousand USD | -79.61% |
| 2011 | 608 Thousand USD | -62.09% |
| 2010 | 1.6 Million USD | -7.28% |
| 2009 | 1.73 Million USD | 127.63% |
| 2008 | 760 Thousand USD | -31.35% |
| 2007 | 1.1 Million USD | 46.04% |
| 2006 | 758 Thousand USD | 28.04% |
| 2005 | 592 Thousand USD | -13.32% |
| 2004 | 683 Thousand USD | -4.87% |
| 2003 | 718 Thousand USD | 6.69% |
| 2002 | 673 Thousand USD | -4.67% |
| 2001 | 706 Thousand USD | 1976.47% |
| 2000 | 34 Thousand USD | -27.66% |
| 1999 | 47 Thousand USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 FY | 6000.00 USD | 100.0% |
| 2022 Q1 | 2000.00 USD | -33.33% |
| 2022 Q2 | 2000.00 USD | 0.0% |
| 2022 Q3 | 7000.00 USD | 250.0% |
| 2022 Q4 | 6000.00 USD | -14.29% |
| 2021 FY | 3000.00 USD | -99.74% |
| 2021 Q1 | 31 Thousand USD | -97.33% |
| 2021 Q2 | 30 Thousand USD | -3.23% |
| 2021 Q3 | 13 Thousand USD | -56.67% |
| 2021 Q4 | 3000.00 USD | -76.92% |
| 2020 Q4 | 1.16 Million USD | 2269.39% |
| 2020 FY | 1.16 Million USD | -1.69% |
| 2020 Q2 | 58 Thousand USD | -9.38% |
| 2020 Q3 | 49 Thousand USD | -15.52% |
| 2020 Q1 | 64 Thousand USD | -94.58% |
| 2019 Q2 | 8000.00 USD | -33.33% |
| 2019 FY | 1.18 Million USD | 49.68% |
| 2019 Q1 | 12 Thousand USD | -98.48% |
| 2019 Q4 | 1.18 Million USD | 10636.36% |
| 2019 Q3 | 11 Thousand USD | 37.5% |
| 2018 Q1 | 704 Thousand USD | -8.81% |
| 2018 Q3 | 761 Thousand USD | 3.82% |
| 2018 Q2 | 733 Thousand USD | 4.12% |
| 2018 Q4 | 789 Thousand USD | 3.68% |
| 2018 FY | 789 Thousand USD | 2.2% |
| 2017 Q4 | 772 Thousand USD | 3.21% |
| 2017 Q1 | 701 Thousand USD | -6.91% |
| 2017 Q3 | 748 Thousand USD | 3.17% |
| 2017 FY | 772 Thousand USD | 2.52% |
| 2017 Q2 | 725 Thousand USD | 3.42% |
| 2016 Q1 | 683 Thousand USD | -27.72% |
| 2016 Q3 | 730 Thousand USD | 3.4% |
| 2016 Q4 | 753 Thousand USD | 3.15% |
| 2016 FY | 753 Thousand USD | -20.32% |
| 2016 Q2 | 706 Thousand USD | 3.37% |
| 2015 FY | 945 Thousand USD | 180.42% |
| 2015 Q4 | 945 Thousand USD | 1.18% |
| 2015 Q1 | 956 Thousand USD | 183.68% |
| 2015 Q2 | 923 Thousand USD | -3.45% |
| 2015 Q3 | 934 Thousand USD | 1.19% |
| 2014 Q1 | 124 Thousand USD | 0.0% |
| 2014 FY | 337 Thousand USD | 171.77% |
| 2014 Q2 | 257 Thousand USD | 107.26% |
| 2014 Q3 | 371 Thousand USD | 44.36% |
| 2014 Q4 | 337 Thousand USD | -9.16% |
| 2013 FY | 124 Thousand USD | 0.0% |
| 2013 Q1 | 124 Thousand USD | 0.0% |
| 2013 Q2 | 124 Thousand USD | 0.0% |
| 2013 Q3 | 124 Thousand USD | 0.0% |
| 2013 Q4 | 124 Thousand USD | 0.0% |
| 2012 FY | 124 Thousand USD | -79.61% |
| 2012 Q1 | - USD | -100.0% |
| 2012 Q3 | 124 Thousand USD | 0.0% |
| 2012 Q2 | 124 Thousand USD | 0.0% |
| 2012 Q4 | 124 Thousand USD | 0.0% |
| 2011 Q4 | 608 Thousand USD | -4.85% |
| 2011 FY | 608 Thousand USD | -62.09% |
| 2011 Q3 | 639 Thousand USD | -54.97% |
| 2011 Q2 | 1.41 Million USD | -9.79% |
| 2011 Q1 | 1.57 Million USD | -1.93% |
| 2010 Q2 | 878 Thousand USD | -0.11% |
| 2010 Q3 | 877 Thousand USD | -0.11% |
| 2010 Q1 | 879 Thousand USD | -49.19% |
| 2010 Q4 | 1.6 Million USD | 82.9% |
| 2010 FY | 1.6 Million USD | -7.28% |
| 2009 Q4 | 1.73 Million USD | 96.37% |
| 2009 Q1 | 759 Thousand USD | -0.13% |
| 2009 Q2 | 758 Thousand USD | -0.13% |
| 2009 Q3 | 881 Thousand USD | 16.23% |
| 2009 FY | 1.73 Million USD | 127.63% |
| 2008 FY | 760 Thousand USD | -31.35% |
| 2008 Q3 | 1.76 Million USD | 68.84% |
| 2008 Q1 | 1.07 Million USD | -2.89% |
| 2008 Q4 | 760 Thousand USD | -56.84% |
| 2008 Q2 | 1.04 Million USD | -2.98% |
| 2007 Q2 | 1.17 Million USD | -0.34% |
| 2007 Q4 | 1.1 Million USD | -2.64% |
| 2007 FY | 1.1 Million USD | 46.04% |
| 2007 Q1 | 1.18 Million USD | 56.07% |
| 2007 Q3 | 1.13 Million USD | -3.56% |
| 2006 Q2 | 582 Thousand USD | -1.36% |
| 2006 Q1 | 590 Thousand USD | -0.34% |
| 2006 Q3 | 575 Thousand USD | -1.2% |
| 2006 Q4 | 758 Thousand USD | 31.83% |
| 2006 FY | 758 Thousand USD | 28.04% |
| 2005 Q2 | 679 Thousand USD | -1.59% |
| 2005 FY | 592 Thousand USD | -13.32% |
| 2005 Q4 | 592 Thousand USD | -11.9% |
| 2005 Q1 | 690 Thousand USD | 1.02% |
| 2005 Q3 | 672 Thousand USD | -1.03% |
| 2004 Q2 | 733 Thousand USD | -7.68% |
| 2004 Q1 | 794 Thousand USD | 10.58% |
| 2004 Q3 | 702 Thousand USD | -4.23% |
| 2004 Q4 | 683 Thousand USD | -2.71% |
| 2004 FY | 683 Thousand USD | -4.87% |
| 2003 FY | 718 Thousand USD | 6.69% |
| 2003 Q1 | 668 Thousand USD | -0.74% |
| 2003 Q3 | 664 Thousand USD | -10.39% |
| 2003 Q4 | 718 Thousand USD | 8.13% |
| 2003 Q2 | 741 Thousand USD | 10.93% |
| 2002 FY | 673 Thousand USD | -4.67% |
| 2002 Q2 | 739 Thousand USD | 6.18% |
| 2002 Q4 | 673 Thousand USD | -7.68% |
| 2002 Q1 | 696 Thousand USD | 0.0% |
| 2002 Q3 | 729 Thousand USD | -1.35% |
| 2001 Q2 | 20 Thousand USD | -4.76% |
| 2001 Q3 | 18 Thousand USD | -10.0% |
| 2001 Q1 | 21 Thousand USD | -8.7% |
| 2001 FY | 706 Thousand USD | 1976.47% |
| 2000 Q1 | 34 Thousand USD | -5.56% |
| 2000 Q3 | 25 Thousand USD | -19.35% |
| 2000 Q2 | 31 Thousand USD | -8.82% |
| 2000 FY | 34 Thousand USD | -27.66% |
| 2000 Q4 | 23 Thousand USD | -8.0% |
| 1999 Q3 | 40 Thousand USD | -6.98% |
| 1999 Q2 | 43 Thousand USD | -8.51% |
| 1999 Q1 | 47 Thousand USD | 0.0% |
| 1999 FY | 47 Thousand USD | 0.0% |
| 1999 Q4 | 36 Thousand USD | -10.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | 99.538% |
| Biocept, Inc. | 10.37 Million USD | 99.942% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 99.988% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 99.99% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | 98.902% |
| iMD Companies, Inc. | 1.1 Million USD | 99.456% |
| IDenta Corp. | 428.17 Thousand USD | 98.599% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 99.859% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | 97.842% |
| NovelStem International Corp. | 3.32 Million USD | 99.82% |
| Optigenex Inc. | 4.42 Million USD | 99.864% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | 99.632% |
| Response Genetics, Inc | 4.91 Million USD | 99.878% |
| Rennova Health, Inc. | 359.19 Thousand USD | 98.33% |
| RushNet, Inc. | 4.25 Million USD | 99.859% |
| ScreenPro Security Inc. | 249.05 Thousand USD | 97.591% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | 99.249% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | 98.959% |
| Todos Medical Ltd. | 33 Million USD | 99.982% |